RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 100 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $8,072,000 | -33.0% | 3,391,717 | +3.4% | 0.00% | -50.0% |
Q3 2016 | $12,044,000 | +66.2% | 3,281,709 | +1.0% | 0.00% | +100.0% |
Q2 2016 | $7,245,000 | +8.0% | 3,248,858 | +0.7% | 0.00% | 0.0% |
Q1 2016 | $6,709,000 | -33.5% | 3,225,374 | -3.1% | 0.00% | -50.0% |
Q4 2015 | $10,089,000 | +25.1% | 3,329,793 | +2.0% | 0.00% | +100.0% |
Q3 2015 | $8,064,000 | -26.6% | 3,264,747 | -4.7% | 0.00% | -50.0% |
Q2 2015 | $10,993,000 | -5.8% | 3,424,517 | +4.8% | 0.00% | 0.0% |
Q1 2015 | $11,671,000 | +57.4% | 3,269,130 | +0.1% | 0.00% | +100.0% |
Q4 2014 | $7,413,000 | +15.1% | 3,265,419 | -1.7% | 0.00% | 0.0% |
Q3 2014 | $6,441,000 | -46.4% | 3,320,223 | +0.2% | 0.00% | -50.0% |
Q2 2014 | $12,028,000 | -2.6% | 3,313,446 | +4.1% | 0.00% | 0.0% |
Q1 2014 | $12,355,000 | +42.7% | 3,184,370 | +4.8% | 0.00% | 0.0% |
Q4 2013 | $8,658,000 | -10.3% | 3,037,933 | +12.7% | 0.00% | 0.0% |
Q3 2013 | $9,653,000 | -1.1% | 2,696,481 | -7.7% | 0.00% | 0.0% |
Q2 2013 | $9,760,000 | – | 2,922,106 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |